Reditus Laboratories: Leading the Way in Pathology Testing and Covid-19 Services
Reditus Laboratories emerged in June 2019 as a dedicated laboratory pathology provider for podiatrist patients in Pekin, IL Over time, the company expanded its services to encompass a wide range of pathology tests on clinical specimens, aiding medical professionals in disease diagnosis, treatment, and prevention.
A Game-Changing Acquisition
In December 2019, Reditus Laboratories made a significant breakthrough by acquiring a real-time reverse transcriptase polymerase chain reaction (RT-PCR) machine This cutting-edge technology enabled the lab to conduct highly sensitive mRNA detection and quantitation, proving instrumental in the mass testing of the American population for the Covid-19 virus
Expanding Capacity
In March 2021, Reditus Labs underwent a substantial expansion, enlarging its laboratory from 2500 sq ft to an impressive 23,000 sq ft This physical growth facilitated the introduction of anatomic pathology services, enabling the diagnosis of soft tissue and wound infections for a diverse range of healthcare providers
Reditus Laboratories Testing Services
With its commitment to excellence, Reditus became a national leader in Covid-19 testing services To date, the laboratory has processed over 3 3 million tests and continues to provide turnkey solutions to schools, universities, and private industry. The company not only offered on-site training and staffing for Covid testing at educational institutions but also supplied the
necessary testing supplies and kits, playing a crucial role in keeping schools open and children healthy throughout the global pandemic.
Unmatched Testing Capacity
Boasting the capability to run 100,000 tests daily, Reditus Labs provided testing services to government organizations, utilizing the ThermoFisher EUA PCR High-throughput testing platform. The company supplied comprehensive test collection kits, including sterile nasal swabs, transport tubes, and viral collection media, ensuring efficient and accurate testing at scale
Exemplary Pandemic Response
Reditus Laboratories operated with exceptional efficiency during its initial years, largely due to its visionary leadership. From supplying essential personal protective equipment to conducting widespread testing, the company significantly contributed to curbing the spread of Covid-19
Pathology Expertise
Prior to gaining national attention for its Covid-related endeavors, Reditus Labs had already established itself as a premier testing lab for podiatry Furthermore, the company had embarked on expanding its services to include urology and histology testing. Through state-of-the-art equipment and clinical laboratory procedures, Reditus delivered accurate diagnoses and valuable insights for the treatment of diseases and injuries, ranging from skin biopsies to wound samples and wart specimens.
Serving Patients and Beyond
Initially launched to provide pathology services to patients and clinicians, Reditus Labs extended its reach to become a national leader in Covid-19 laboratory testing for universities, local school districts, corporate entities, and government organizations. The company offered customized services tailored to the unique challenges and requirements of each population, working closely with HR departments to implement effective communicable disease testing and surveillance programs.
Community Engagement
Recognizing the importance of mass testing, Reditus swiftly organized concierge events at public locations, offering drive-up, walk-in, and appointment-based testing services to the general population. With a remarkable capacity to conduct over 40,000 Covid-19 tests per day, boasting specificity and sensitivity levels exceeding 98 9%, Reditus played a pivotal role in ensuring community safety and facilitating a return to normalcy
Meet the Leadership Team
Dr. Aaron Rossi, MD, founded and served as CEO of Reditus Laboratories. With a medical degree from the University of Sint Eustatius School of Medicine and a proven talent for private medical practice management, Dr Rossi's leadership propelled the company's success
Dr Lawrence J Rossi, Jr, MD, joined Reditus as President, bringing over 40 years of medical patient service experience With a diverse background as a pediatrician, critical care physician, anesthesiologist, and pain management specialist, Dr. Rossi contributed invaluable healthcare operations expertise acquired during his tenure at Hopedale Medical Complex in Hopedale, Illinois.
Michelle Anderson, as Director of Operations, skillfully managed Reditus Laboratories' Molecular Laboratory. As a certified medical laboratory technician with extensive experience in analyzing diseased tissue and fluids, she ensured the performance and development of diagnostic tests Ms Anderson pursued ongoing education at the University of Cincinnati after completing her degree from Illinois Central College in 1994.
Dr Jerome Anderson, D O , served as the Medical Director of Reditus Laboratories, overseeing clinical support and coordinating teams for patient care With a Doctor of Osteopathic Medicine degree from the Chicago College of Osteopathic Medicine, Dr. Anderson brought invaluable expertise gained during ten years of active duty in the United States Air Force and his role as Medical Director at McDonough District Hospital in Macomb, Illinois
Reditus Laboratories stands at the forefront of laboratory pathology and Covid-19 testing services. With a commitment to accuracy, accessibility, and fast turnaround times, the company has made a significant impact on patient care, education, corporate testing, and community well-being Through the visionary leadership of Dr Aaron Rossi and the expertise of the entire
team, Reditus Labs continues to drive innovation in the field of pathology and advance public health initiatives.